MKMarc A. Kowalkowski

Marc A. Kowalkowski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marc A. Kowalkowski has a total of 201 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Sepsis Diagnostic Excellence and Its Association With Mortality in Adults With Potential Infection

    by Marc Kowalkowski, Sarah Birken, Corey Obermiller, Chadwick D Miller, Jessica A Palakshappa, Bradley Rowland, Jessie King, Timothy Rogers, Shuo Tian, Sachita Shrestha, et al.

    Background: Diagnostic uncertainty in sepsis contributes to both undertreatment (delayed antibiotics) and overtreatment (unnecessary early antibiotics in nonsepsis patients). We hypothesized hospitals with strong sepsis undertreatment and overtreatment performance have better outcomes. Methods: We conducted a retrospective cohort study of hospitalized adults at 20 hospitals (Advocate Health, Michigan Medicine) between 2022 and 2024. Patients met ≥2 systemic inflammatory response syndrome criteria within 6 hours of presentation. Hospital performance was characterized using risk-standardized rates (RSRs) for undertreatment and overtreatment. “Diagnostic excellence” (DxEx) was prespecified as top-tertile performance in 1 measure without bottom-tertile performance in the other. The primary outcome was hospital mortality or hospice discharge. Secondary outcomes were hospital-free days alive at 28 days (HFD), length of stay (LOS), and total antibiotic days. Results: Among 152 779 patients, 49 109 (32.1%) received antibiotics within 3 hours and 16 361 (10.7%) ultimately met sepsis criteria. Undertreatment RSRs ranged from 29.3% to 46.8%. Overtreatment RSRs ranged from 21.5% to 37.2%. There was negative correlation between performance ranks (τ = −0.51; P = .01). Four hospitals met DxEx criteria. Receiving treatment at DxEx hospitals was associated with lower hospital mortality or hospice discharge (adjusted OR = 0.61; 95% CI = .41–.90; P = .01), greater HFD (adjusted difference = 0.59; 95% CI = .04–1.14; P = .04), reduced LOS (adjusted difference = −1.20; 95% CI = −2.23 to −.17; P = .02), and fewer antibiotic days (adjusted difference = −0.62; 95% CI = −1.28–.05; P = .07), versus non-DxEx hospitals. Conclusions: Hospital performance that jointly minimizes sepsis undertreatment and overtreatment was associated with improved patient outcomes, adjusting for patient and hospital factors. Findings highlight the importance of reducing diagnostic error in efforts to improve sepsis outcomes.

  • Hospital‐at‐home for COPD: A retrospective comparison with brick‐and‐mortar settings

    by Hieu M. Nguyen, Marc Kowalkowski, Timothy C. Hetherington, McKenzie Isreal, Stephanie Murphy

    The recent Acute Hospital Care at Home (AHCaH) initiative has increased Hospital‐at‐Home (HaH) access and utilization, but it is unknown how care delivery differs between AHCaH‐compliant HaH programs and brick‐and‐mortar (BaM) inpatient care—specifically for common, costly hospital conditions like chronic obstructive pulmonary disease (COPD). In this retrospective cohort study, we compared management and outcomes for adults hospitalized with COPD treated in HaH and BaM settings in 2022. We analyzed EHR data from 297 adults who were eligible for HaH, including 119 who remained in BaM and 178 in HaH. HaH patients had higher likelihood of orders for supplemental oxygen (risk ratio [RR]: 1.04, 95% confidence interval [CI]: 1.01–1.09) and bronchodilators (RR: 1.12, 95% CI: 1.04–1.20), compared to BaM. HaH patients also had higher mean 30‐day acute care‐free days alive (mean ratio [MR]: 1.04, 1.01–1.08). Our findings suggest similar or improved guideline‐directed therapy and outcomes for COPD patients treated in HaH.


  • Collaborative development of a rules‐based electronic health record algorithm for Hospital‐at‐Home eligibility

    by Tsai‐Ling Liu, Timothy C. Hetherington, Marc Kowalkowski, Marvin E. Knight, Jamayla Culpepper, Andrew McWilliams, Shih‐Hsiung Chou, McKenzie Isreal, Stephanie Murphy

    Identifying appropriate patients for hospital at Home (HaH) is challenged by the extensive inpatient population, the dynamic nature of hospitalizations, and the eligibility window for entry into the care model. This study presents the development of a rules‐based algorithm (RBA) leveraging electronic health record (EHR) data to improve HaH patient identification, which is crucial for efficient HaH operations. RBA adjustments incorporated clinician feedback to align analytics resources and enhance clinical workflows. Our study highlights the importance of interdisciplinary collaboration and the potential for analytics to optimize efficiency for emerging care models.


  • Open Access

    External validation of a proprietary risk model for 1-year mortality in community-dwelling adults aged 65 years or older

    by Erica Frechman, Byron C Jaeger, Marc Kowalkowski, Jeff D Williamson, Kristin M Lenoir, Jessica A Palakshappa, Brian J Wells, Kathryn E Callahan, Nicholas M Pajewski, Jennifer L Gabbard

    Objective: To examine the discrimination, calibration, and algorithmic fairness of the Epic End of Life Care Index (EOL-CI). Materials and Methods: We assessed the EOL-CI’s performance by estimating area under the receiver operating characteristic curve (AUC), sensitivity, and positive and negative predictive values in community-dwelling adults ≥65 years of age in a single health system in the Southeastern United States. Algorithmic fairness was examined by comparing the model’s performance across sex, race, and ethnicity subgroups. Using a machine learning approach, we also explored local re-calibration of the EOL-CI considering additional information on past hospitalizations and frailty. Results: Among 215 731 patients (median age = 74 years, 57% female, 12% of Black race), 10% were classified as medium risk (15-44) and 3% as high risk (≥45) by the EOL-CI. The observed 1-year mortality rate was 3%. The EOL-CI had an AUC 0.82 for 1-year mortality, with a positive predictive value of 22%. Predictive performance was generally similar across sex and race subgroups, though the EOL-CI displayed better performance with increasing age and in older adults with 2 or more outpatient encounters in the past 24 months. Local re-calibration of the EOL-CI was required to provide absolute estimates of mortality risk, and calibration was further improved when the EOL-CI was augmented with data on inpatient hospitalizations and frailty. Discussion: The EOL-CI demonstrates reasonable discrimination, albeit with better performance in older adults and in those with greater health system contact. Conclusion: Local refinement and calibration of the EOL-CI score is required to provide direct estimates of prognosis, with the goal of making the EOL-CI a more a valuable tool at the point of care for identifying patients who would benefit from targeted palliative care interventions and proactive care planning.


  • Hospital Variation in Response to CDC Sepsis Program Core Elements Assessment Tool

    by Marc Kowalkowski, Sarah Birken, Chadwick D. Miller, Jessica A. Palakshappa, Jessie King, Stephanie Taylor


  • Open Access

    Diagnostic safety and quality optimization in sepsis study protocol

    by Sachita Shrestha, Marc Kowalkowski, Sarah Birken, Jessica Palakshappa, Jessie King, Chadwick Miller, Jason Pogue, Stephanie Taylor

    Background: Sepsis ranks among the “Big Three" conditions most prone to harmful diagnostic errors. Despite its high prevalence and severity, health systems lack effective and contextually tailored strategies to optimize diagnostic accuracy for sepsis.Objectives: The purpose of this study is to understand factors related to high sepsis diagnostic accuracy using principles and tools of safety and implementation science.Methods: This is a multi‐site study involving 20 hospitals across four states in the United States. The primary objectives are to (1) describe hospital‐level variability and understand barriers and facilitators to sepsis diagnostic accuracy and (2) apply cross‐case and coincidence analysis to determine minimally sufficient and necessary conditions for optimal sepsis diagnosis that minimizes under‐ and overtreatment. To identify barriers and facilitators of acute sepsis diagnosis, we will conduct electronic surveys and in‐depth interviews with key informants from each hospital. We will use data from electronic health records (EHR) and data warehouses to operationalize sepsis diagnostic accuracy.Results: We have enrolled 20 hospitals and begum data collection. The findings of this study will be used to develop a context‐specific toolkit that guides the selection of feasible and important strategies to promote optimal sepsis diagnosis in diverse hospitals settings.Conclusions: The study uses tools and principles from safety and implementation science to generate first‐of‐its‐kind evidence to improve diagnostic excellence in sepsis.


  • A time‐series analysis examining implementation strategies to increase use of an early‐supported discharge hospital at home model

    by Padageshwar Sunkara, Raghava Nagaraj, Hieu Nguyen, Stephanie Murphy, Kevin Goslen, Harsh Barot, Timothy Hetherington, Casey Stephens, McKenzie Isreal, Marc Kowalkowski

    Background: Early‐supported discharge (ESD) hospital‐at‐home (HaH) programs facilitate hospitalized patients to receive ongoing acute‐level care at home, thereby promoting patient‐centeredness while improving hospital throughput.Objectives: The current study aimed to test multiple implementation strategies to increase and sustain HaH ESD utilization.Methods: We conducted interrupted time series analyses to evaluate the effectiveness of implementation strategies on weekly HaH ESD referrals and capacity utilization at five hospitals. Intervention 1 included provider‐focused education and HaH nurse navigator support (July 2021 to May 2022). Intervention 2 added provider‐level referral performance feedback and daily electronic health record‐based eligibility reports (May 2022 to December 2022). During postintervention (January 2023 to June 2023), implementation strategies were no longer supported by the study team. Clinical outcomes were assessed over time and between patient subgroups.Results: There were 5951 HaH ESD patients overall. After Intervention 2, we observed immediate increases in weekly HaH ESD referrals (level change mean difference [MD, 95% confidence interval]: 14.8, 5.9–23.6) and capacity utilization (level change MD: 13.9%, 6.2%–21.5%) and additional week‐to‐week increases in capacity utilization (slope change MD: 0.6%, 0.2%–0.9%), compared to Intervention 1 trends. HaH ESD referrals and capacity utilization were sustained postintervention. The proportion of provider‐initiated referrals increased over time (Intervention 1: 79.4%, Intervention 2: 90.9%, postintervention: 95.2%). As HaH ESD utilization increased, we observed shorter inpatient length of stay and fewer HaH ESD encounters per visit (p < 0.01). There were small, statistically significant differences in 30‐day mortality and readmission for residents of rural and socioeconomically disadvantaged areas.Conclusion: Applying referral‐focused provider feedback and daily eligibility reports were effective within a multicomponent approach to increase and sustain HaH ESD utilization.


  • Open Access

    Development of an Electronic Clinical Surveillance Measure for Unnecessary Rapid Antibiotic Administration in Suspected Sepsis

    by Stephanie Parks Taylor, Jessica A Palakshappa, Shih-Hsiung Chou, Kevin Gibbs, Jessie King, Nikhil Patel, Marc Kowalkowski

    Substantial efforts focus on monitoring and reducing delays in antibiotic treatment for sepsis, but little has been done to characterize the balancing measure of sepsis overtreatment. We aimed to establish preliminary validity and usefulness of electronic health record (EHR) data–derived criteria for sepsis overtreatment surveillance (SEP-OS). We evaluated adults with potential sepsis (≥2 Systemic Inflammatory Response Syndrome criteria within 6 hours of arrival) presenting to the emergency department of 12 hospitals, excluding patients with shock. We defined SEP-OS as the proportion of patients receiving rapid IV antibiotics (≤3 hours) who did not ultimately meet the Centers for Disease Control Adult Sepsis Event “true sepsis” definition. We evaluated the frequency and characteristics of patients meeting overtreatment criteria and outcomes associated with sepsis overtreatment. Of 113 764 eligible patients, the prevalence of sepsis overtreatment was 22.5%. The measure met prespecified criteria for reliability, content, construct, and criterion validity. Patients classified by the SEP-OS overtreatment criteria had higher median antibiotic days (4 days [IQR, 2–5] vs 1 day [1–2]; P < .01), longer median length of stay (4 days [2–6] vs 3 days [2–5]; P < .01), higher hospital mortality (2.4% vs 2.1%; P = .01), and higher frequency of Clostridium difficile infection within 6 months of hospital discharge (P < .01) compared with “true negative” cases. We developed a novel, valid EHR metric for clinical surveillance of sepsis overtreatment. Applying this metric to a large cohort of potential sepsis patients revealed a high rate of overtreatment and provides a useful tool to inform sepsis quality-improvement targets.


  • Patient and care team perspectives on an app to support Hospital at Home admission decision making

    by Justin Kramer, Marc Kowalkowski, Kelly Reeves, Tara Eaton, Shih‐Hsiung Chou, Stephanie Murphy, Colleen Hole, Asha Ganesan, Andrew McWilliams

    Background: Hospital at Home (HaH) programs are used throughout the United States and are beneficial in both providing patients care in environments most comfortable to them and freeing up inpatient beds. Better informing patients about HaH programs, while promoting shared decision‐making (SDM), should be prioritized by health systems. SDM apps may promote increased patient agency and understanding of complex HaH care decisions. We previously developed, usability tested, and refined a HaH SDM app.Objectives: To evaluate the utility of SDM apps in assisting pneumonia patients with HaH admission.Methods: Usability surveys (N = 16) and semistructured interviews with patients (N = 9) and nurse navigators (N = 3) were utilized to evaluate our app in assisting pneumonia patients as they contemplated HaH admission. Recruitment occurred at three hospitals in the southeastern United States. Surveys were analyzed consistent with their validated measures, while interviews were analyzed using inductive coding methodologies.Results: Patients supported receiving HaH information via an app, with many noting that presenting content via multiple modalities (e.g., videos, pictures, text) was helpful and that the app assisted their care decision. App‐guided inquiries into patients' care preferences helped patients visualize their priorities and promoted feelings of agency, while providing important information to care teams. Participants found visuals effective at conveying program details, for example, HaH's in‐home setup, which may assist with health literacy challenges. Potential barriers included the need to expand app accessibility for vision impaired and non‐English speaking patients.Conclusions: SDM apps may better inform patients' HaH care decisions, allowing patients self‐directed access to information and engagement with visual content, which may address challenges related to health literacy and navigating complex, time‐sensitive decisions.


  • Effectiveness of a Multifaceted Implementation Strategy to Increase Equitable Hospital at Home Utilization: An Interrupted Time Series Analysis

    by Marc Kowalkowski, Casey Stephens, Timothy Hetherington, Hieu Nguyen, Henry Bundy, McKenzie Isreal, Colleen Hole, Padageshwar Sunkara, Raghava Nagaraj, Kranthi Sitammagari, et al.

    Background The number of Hospital-at-Home (HaH) programs rapidly increased during the COVID-19 pandemic and after issuance of Centers for Medicare and Medicaid Services’ (CMS) Acute Hospital Care at Home (AHCaH) waiver. However, there remains little evidence on effective strategies to equitably expand HaH utilization. Objective Evaluate the effects of a multifaceted implementation strategy on HaH utilization over time. Design Before and after implementation evaluation using electronic health record (EHR) data and interrupted time series analysis, complemented by qualitative interviews with key stakeholders. Participants Between December 2021 and December 2022, we identified adults hospitalized at six hospitals in North Carolina approved by CMS to participate in the AHCaH waiver program. Eligible adults met criteria for HaH transfer (HaH-eligible clinical condition, qualifying home environment). We conducted semi-structured interviews with 12 HaH patients and 10 referring clinicians. Interventions Two strategies were studied. The discrete implementation strategy (weeks 1–12) included clinician-directed educational outreach. The multifaceted implementation strategy (weeks 13–54) included ongoing clinician-directed educational outreach, local HaH assistance via nurse navigators, involvement of clinical service line executives, and individualized audit and feedback. Measures We assessed weekly averaged HaH capacity utilization, weekly counts of unique referring providers, and patient characteristics. We analyzed themes from qualitative data to determine barriers and facilitators to HaH use. Results Our evaluation showed week-to-week increases in HaH capacity utilization during the multifaceted implementation strategy period, compared to discrete-period trends (slope-change odds ratio—1.02, 1.01–1.04). Counts of referring providers also increased week to week, compared to discrete-period trends (slope-change means ratio—1.05, 1.03–1.07). The increase in HaH utilization was largest among rural residents (11 to 34%). Barriers included HaH-related information gaps and referral challenges; facilitators included patient-centeredness of HaH care. Conclusions A multifaceted implementation strategy was associated with increased HaH capacity utilization, provider adoption, and patient diversity. Health systems may consider similar, contextually relevant multicomponent approaches to equitably expand HaH.